Adult-type rhabdomyosarcoma: Analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis

American Journal of Surgical Pathology

Volumn 33, Issue 12, 2009, Pages 1850-1859

  Stock, Nathalie ^a,b   Chibon, Frederic ^a   Nguyen Binh, Matthieu Bui ^a,b   Terrier, Philippe ^c   Michels, Jean Jacques ^d   Valo, Isabelle ^e   Robin, Yves Marie ^f   Guillou, Louis ^g   Ranchère Vince, Dominique ^h   Decouvelaere, Anne Valérie ^h   Collin, Francoise ⁱ   Birtwisle Peyrottes, Isabelle ^j   Gregoire, Fleur ^a   Aurias, Alain ^k   Coindre, Jean Michel ^a,b  

^a INSTITUT BERGONIÉ   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d Cancer Institute   (France)

^e CENTRE PAUL PAPIN   (France)

^f CENTRE OSCAR LAMBRET   (France)

^g CENTRE LÉON BÉRARD   (France)

^h Georges Francois Leclerc Center   (France)

ⁱ CENTRE ANTOINE LACASSAGNE   (France)

^j INSTITUT CURIE   (France)

^k UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

more..

Author keywords

Immunohistochemistry; Rhabdomyosarcoma; Soft tissue

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CHEMISTRY; COMPARATIVE GENOMIC HYBRIDIZATION; DIFFERENTIAL DIAGNOSIS; DISEASE FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KAPLAN MEIER METHOD; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; RHABDOMYOSARCOMA; SOFT TISSUE TUMOR; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

RHABDOMYOSARCOMA; ADULT; AGED; AGED, 80 AND OVER; COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSIS, DIFFERENTIAL; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SOFT TISSUE NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 73349096624     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181be6209     Document Type: Article

References (31)

1. Bahrami A, Gown AM, Baird GS, et al. Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosar-coma: a potentially serious diagnostic pitfall. Mod Pathol. 2008;21: 795-806.
2. Barr FG. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene. 2001;20:5736-5746.
3. Binh MB, Sastre-Garau X, Guillou L, et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol. 2005;29:1340-1347.
4. Binh MB, Guillou L, Hostein I, et al. Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas. Am J Surg Pathol. 2007;31:1557-1566.
5. Cavazzana AO, Schmidt D, Ninfo V, et al. Spindle cell rhabdomyo-sarcoma. A prognostically favorable variant of rhabdomyosarcoma. Am J Surg Pathol. 1992;16:229-235.
6. Cessna MH, Zhou H, Perkins SL, et al. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol. 2001;25: 1150-1157.
7. de Jong AS, van Kessel-van Vark M, Albus-Lutter CE. Pleomorphic rhabdomyosarcoma in adults: immunohistochemistry as a tool for its diagnosis. Hum Pathol. 1987;18:298-303.
8. Ferrari A, Dileo P, Casanova M, et al. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer. 2003;98:571-580.
9. Folpe AL, McKenney JK, Bridge JA, et al. Sclerosing rhabdomyo-sarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteo-sarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol. 2002;26:1175-1183.
10. Furlong MA, Mentzel T, Fanburg-Smith JC. Pleomorphic rhabdo-myosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers. Mod Pathol. 2001;14:595-603.
11. Gaffney EF, Dervan PA, Fletcher CD. Pleomorphic rhabdomyo-sarcoma in adulthood. Analysis of 11 cases with definition of diagnostic criteria. Am J Surg Pathol. 1993;17:601-609.
12. Guillou L, Coindre JM, Bonichon F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol. 1997;15:350-362.
13. Hawkins WG, Hoos A, Antonescu CR, et al. Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer. 2001;91:794-803.
14. Hollowood K, Fletcher CD. Rhabdomyosarcoma in adults. Semin Diagn Pathol. 1994;11:47-57.
15. Kuhnen C, Herter P, Leuschner I, et al. Sclerosing pseudovascular rhabdomyosarcoma-immunohistochemical, ultrastructural, and genetic findings indicating a distinct subtype of rhabdomyosarcoma. Virchows Arch. 2006;449:572-578.
16. Kumar S, Perlman E, Harris CA, et al. Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues. Mod Pathol. 2000;13:988-993.
17. Leuschner I, Newton WA Jr, Schmidt D, et al. Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region. A report of the Intergroup Rhabdomyosarcoma Study. Am J Surg Pathol. 1993;17:221-230.
18. Little DJ, Ballo MT, Zagars GK, et al. Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer. 2002;95: 377-388.
19. Mentzel T, Katenkamp D. Sclerosing, pseudovascular rhabdomyo-sarcoma in adults. Clinicopathological and immunohistochemical analysis of three cases. Virchows Arch. 2000;436:305-311.
20. Mentzel T, Kuhnen C. Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases. Virchows Arch. 2006;449:554-560.
21. Miettinen M. Rhabdomyosarcoma in patients older than 40 years of age. Cancer. 1988;62:2060-2065.
22. Morotti RA, Nicol KK, Parham DM, et al. An immunohistochem-ical algorithm to facilitate diagnosis and subtyping of rhabdomyo-sarcoma: the Children's Oncology Group experience. Am J Surg Pathol. 2006;30:962-968.
23. Nascimento AF, Fletcher CD. Spindle cell rhabdomyosarcoma in adults. Am J Surg Pathol. 2005;29:1106-1113.
24. Rangdaeng S, Truong LD. Comparative immunohistochemical staining for desmin and muscle-specific actin. A study of 576 cases. Am J Clin Pathol. 1991;96:32-45.
25. Rubin BP, Hasserjian RP, Singer S, et al. Spindle cell rhabdomyo-sarcoma (so-called) in adults: report of two cases with emphasis on differential diagnosis. Am J Surg Pathol. 1998;22:459-464.
26. Sirvent N, Coindre JM, Maire G, et al. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR. Am J Surg Pathol. 2007;31:1476-1489.
27. Skalli O, Gabbiani G, Babai F, et al. Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. II. Rhabdomyosarcomas. Am J Pathol. 1988;130: 515-531.
28. Stout AP. Rhabdomyosarcoma of skeletal muscles. Ann Surg. 1946;123:447-472.
29. Wang J, Tu X, Sheng W. Sclerosing rhabdomyosarcoma: a clinico-pathologic and immunohistochemical study of five cases. Am J Clin Pathol. 2008;129:410-415.
30. Woodruff JM, Perino G. Non-germ-cell or teratomatous malignant tumors showing additional rhabdomyoblastic differentiation, with emphasis on the malignant Triton tumor. Semin Diagn Pathol. 1994; 11:69-81.
31. Zhou H, Coffin CM, Perkins SL, et al. Malignant peripheral nerve sheath tumor: a comparison of grade, immunophenotype, and cell cycle/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions. Am J Surg Pathol. 2003;27: 1337-1345.